Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil PK and Safety in Pediatric PAH
NCT01484431Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2012
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of tadalafil in pulmonary arterial hypertension (PAH), sponsored by Eli Lilly and Company. Started Jul 2012; status: completed.
02
Drugs
tadalafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01484431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01484431.